Lonza

Top-Feature

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Global Gateway Advisors
Photo
Lonza AG
Microinnova Engineering GmbH
Camelot Management Consultants AG
GETEC Group
PP Consulting
Photo
Mack Brooks Exhibition Ltd – Part of RX
Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences
Photo
Arxada AG
Photo
DCAT - Drug, Chemical & Associated Technologies Association
Frost & Sullivan
Jan Ramakers Fine Chemical
Pricewaterhouse Coopers
Thomson Reuters
Photo
Fraser Dove International
F. Hoffmann-La Roche Ltd